1. Ersahin Y. Craniopharyngiomas. Turkiye Klinikleri J Surg Med Sci2007;3(34):170-174.
2. Haspolat YK, Yıldırım ZB, Kavak GÖ. Endokrin Hastalıklar veAnestezi. 2020;47-51.
3. Nemergut EC, Dumont AS, Barry UT, et al. Perioperative managementof patients undergoing transsphenoidal pituitary surgery. Anesth Anal.2005;101(4):1170-1181. doi: 10.1213/01.ane.0000166976.61650.ae
4. Vance ML. Treatment of patients with a pituitary adenoma:oneclinician’s experience. Neurosurg Focus 2004;16(4):1-6. doi: 10.3171/foc.2004.16.4.2
5. Dunn LT. Raised intracranial pressure. J Neurol Neurosurg Psychiatry2002;73(Suppl-1):i23-i7.
6. Haspolat YK, Yıldırım ZB, Kavak GO. Endocrine Diseases andAnesthesia. 2020;47-51.
7. McClain CD, Soriano SG, Rockoff MA. Pediatric NeurosurgicalAnesthesia. In: Cote CJ, Lerman J, Anderson BJ (Eds). A Practice ofAnesthesia for infants and children. Philadelphia: Elsevier. 2013;510-32.
8. Slater P, Gupta K. Etomidate and injection pain in children. Br JAnaesth. 2007;98:545-552.
9. Dunn LK, Nemergut EC. Anesthesia for transsphenoidal pituitarysurgery. Curr Opin Anesthesiol. 2013;26(5):549-54. doi: 10.1097/01.aco.0000432521.01339.ab
10. Gemma M, Tommasino C, Cozzi S, et al. Remifentanil provideshemodynamic stability and faster awakening time in transsphenoidalsurgery. Anesth Analg. 2002;94(1):163-168. doi: 10.1213/00000539-200201000-00031
11. Artru AA, Sperry RJ, Lam M, Johnson J. Intracranial pressure,middle cerebral artery flow velocity, and plasma inorganic fluorideconcentrations in neurosurgical patients receiving sevoflurane orisoflurane. Anesth Analg. 1997;85:587-592.
12. Tipps LB, Coplin WM, Murry KR, Rhoney DH. Safety and feasibilityof continuous infusion of remifentanil in the neurosurgical intensivecare unit. Neurosurgery. 2000;46(3):596-602. doi: 10.1097/00006123-200003000-00015
13. Fukushima T, Maroon JC. Repair of carotid artery perforations duringtranssphenoidal surgery. Surg Neurol. 1998;50(2):174-177. doi: 10.1016/S0090-3019(96)00416-8
14. Krieger DW, Yenari MA. Therapeutic hypothermia for acute ischemicstroke:what do laboratory studies teach us? Stroke. 2004;35(6):1482-9.
15. Liu L, Yenari MA. Therapeutic hypothermia: neuroprotectivemechanisms. Front Biosci. 2007;12:816-25.
16. Zgavc T, Ceulemans AG, Hachimi-Idrissi S, Kooijman R, Sarre S,Michotte Y. The neuroprotective effect of post ischemic brief mildhypothermic treatment correlates with apoptosis, but not with gliosis inendothelin-1 treated rats. BMC Neurosci. 2012;13:105
17. Porter JM1, Pidgeon C, Cunningham AJ. The sitting position inneurosurgery:a critical appraisal. Br J Anaesth. 1999;82(1):117-28.
18. An updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology.2011;114(3):495-511.
19. Sumpelmann R1, Becke K2, Brenner S3, et al. Perioperativeintravenous fluid therapy in children:guidelines from the Associationof the Scientific Medical Societies in Germany. Paediatr Anaesth.2017;27(1):10-18. doi: 10.1111/pan.13007.
20. Soriano SG1, Eldredge EA, Rockoff MA.Pediatric neuroanesthesia.Neuroimaging Clin N Am. 2007;17(2):259-67.
21. Singh GP, Prabhakar H, Bithal PK, et al. A retrospective analysis ofperioperative complications during intracranial neuroendoscopicprocedures: Our institutional experience. Neurology India. 2011;59:874-8.
22. Fabregas N, Craen R A. Anaesthesia for endoscopic neurosurgicalprocedures. Curr Opin Anaesthesiol. 2010;23:568-75.